🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsSide Effects & ManagementGallbladder disease risk — my results so far Page 4

Gallbladder disease risk — my results so far

COA_Karl Fri, Jul 11, 2025 at 10:38 PM 27 replies 1,432 viewsPage 4 of 6
JenMemphis
Member
267
1,234
Jan 2025
Memphis, TN
Jul 12, 2025 at 4:18 AM#16

Congrats LarryQC_SD!! Keep going — you're doing incredible. 🎉 👏

15 2MikeKY_noInsulin, Dr.RaviCardio, jennifer_SEA and 12 others
Reply Quote Save Share Report
MarkLI_maint
Member
534
2,345
Jun 2024
Long Island, NY
Jul 12, 2025 at 4:35 AM#17

Exactly this. My pharmacist said the same thing about Gallbladder disease.

2 17TrialNerd_Beth, HPLC_Greg
Reply Quote Save Share Report
Dr.PathRoch
Member
456
2,123
Jun 2024
Rochester, MN
Jul 12, 2025 at 4:52 AM#18
LarryQC_SD said:
Gallbladder disease risk my is not that straightforward in my experience

This is exactly right. LarryQC_SD articulated what I have been trying to explain to my friends for months. The Gallbladder disease risk aspect is what made the difference for me.

40 0WendyG_ATL, SaraMom3, Dr.MetabolicMD and 37 others
Reply Quote Save Share Report
josh_phd_bmore
Member
389
1,678
Jul 2024
Baltimore, MD
Jul 12, 2025 at 5:09 AM#19

Same experience here with Gallbladder disease risk . Dr.PathRoch described it perfectly.

22 10KarenAZ_mom, zoe_NC, Dr.ObesityLA and 19 others
Reply Quote Save Share Report
InsuranceTom
Senior Member
1,345
7,890
Mar 2024
Connecticut
Jul 12, 2025 at 5:26 AM#20

Slightly tangential to Gallbladder disease risk but MarkLI_maint reminded me — has anyone else noticed changes in their alcohol tolerance?

I know it is not exactly on-topic but it seems related enough to ask here rather than starting a new thread. Apologies if this has been covered — I did search first.

14 15jim_asheville, matt_MKE, Dr.ReproEndo and 11 others
Reply Quote Save Share Report

Similar Threads

Nausea incidence by dose tier — STEP and SURMOUNT meta-analysis16 replies
Constipation on GLP-1: pathophysiology and fiber protocol5 replies
Alopecia on GLP-1 — telogen effluvium differential diagnosis3 replies
Gallbladder disease risk — cholelithiasis data from clinical trials12 replies
Pancreatitis risk assessment — pooled safety analysis15 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register